199 related articles for article (PubMed ID: 31196149)
1. Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III.
Lin HY; Chen MR; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
Orphanet J Rare Dis; 2019 Jun; 14(1):140. PubMed ID: 31196149
[TBL] [Abstract][Full Text] [Related]
2. Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II.
Lin HY; Chen MR; Lee CL; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
Orphanet J Rare Dis; 2021 Feb; 16(1):99. PubMed ID: 33622387
[TBL] [Abstract][Full Text] [Related]
3. Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA.
Lin HY; Chen MR; Lin SM; Hung CL; Niu DM; Chuang CK; Lin SP
Orphanet J Rare Dis; 2018 Aug; 13(1):148. PubMed ID: 30157891
[TBL] [Abstract][Full Text] [Related]
4. Natural history of echocardiographic abnormalities in mucopolysaccharidosis III.
Wilhelm CM; Truxal KV; McBride KL; Kovalchin JP; Flanigan KM
Mol Genet Metab; 2018 Jun; 124(2):131-134. PubMed ID: 29735373
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Evaluation using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses.
Lin HY; Chuang CK; Lee CL; Chen MR; Sung KT; Lin SM; Hou CJ; Niu DM; Chang TM; Hung CL; Lin SP
Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979324
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis.
Lin SM; Lin HY; Chuang CK; Lin SP; Chen MR
Mol Genet Metab; 2014 Apr; 111(4):493-8. PubMed ID: 24598247
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.
Kampmann C; Lampe C; Whybra-Trümpler C; Wiethoff CM; Mengel E; Arash L; Beck M; Miebach E
J Inherit Metab Dis; 2014 Mar; 37(2):269-76. PubMed ID: 24062198
[TBL] [Abstract][Full Text] [Related]
8. Cardiac manifestations of the mucopolysaccharidoses.
Schieken RM; Kerber RE; Ionasescu VV; Zellweger H
Circulation; 1975 Oct; 52(4):700-5. PubMed ID: 808361
[TBL] [Abstract][Full Text] [Related]
9. Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy.
Lin HY; Chen MR; Lee CL; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33374885
[TBL] [Abstract][Full Text] [Related]
10. Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.
Soliman OI; Timmermans RG; Nemes A; Vletter WB; Wilson JH; ten Cate FJ; Geleijnse ML
J Inherit Metab Dis; 2007 Oct; 30(5):750-7. PubMed ID: 17574537
[TBL] [Abstract][Full Text] [Related]
11. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.
Lin HY; Chuang CK; Chen MR; Lin SM; Hung CL; Chang CY; Chiu PC; Tsai WH; Niu DM; Tsai FJ; Lin SJ; Hwu WL; Lin JL; Lin SP
Mol Genet Metab; 2016 Apr; 117(4):431-7. PubMed ID: 26899310
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
[TBL] [Abstract][Full Text] [Related]
13. Tissue doppler echocardiographic evaluation of cardiac functions in children with mucopolysaccharidosis type III disease.
Altin H; Dorum S; Ture E
Niger J Clin Pract; 2022 Oct; 25(10):1717-1724. PubMed ID: 36308245
[TBL] [Abstract][Full Text] [Related]
14. Cardiac disease in mucopolysaccharidosis type III.
Nijmeijer SCM; de Bruin-Bon RHACM; Wijburg FA; Kuipers IM
J Inherit Metab Dis; 2019 Mar; 42(2):276-285. PubMed ID: 30671988
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic studies of left ventricular wall motion and dimensions after valvular heart surgery.
Burggraf GW; Craige E
Am J Cardiol; 1975 Apr; 35(4):473-80. PubMed ID: 1119397
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI].
Azak E; Gündüz M
Turk Kardiyol Dern Ars; 2019 Oct; 47(7):587-593. PubMed ID: 31582674
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.
Schroeder L; Orchard P; Whitley CB; Berry JM; Tolar J; Miller W; Braunlin EA
JIMD Rep; 2013; 10():87-94. PubMed ID: 23430808
[TBL] [Abstract][Full Text] [Related]
18. Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.
Wethal T; Lund MB; Edvardsen T; Fosså SD; Pripp AH; Holte H; Kjekshus J; Fosså A
Br J Cancer; 2009 Aug; 101(4):575-81. PubMed ID: 19623176
[TBL] [Abstract][Full Text] [Related]
19. Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.
Honjo RS; Vaca ECN; Leal GN; Abellan DM; Ikari NM; Jatene MB; Martins AM; Kim CA
BMC Med Genet; 2020 Feb; 21(1):37. PubMed ID: 32075597
[TBL] [Abstract][Full Text] [Related]
20. [Cardiac manifestation of the mucopolysaccharidoses: periodical echocardiographic evaluation in six cases].
Tada A; Tanaka A; Yasuda M; Komatsu Y; Inoue E; Minamikawa H; Kozumi K; Yoshimura T; Ikuno Y; Oku H
J Cardiogr; 1983 Jun; 13(2):407-23. PubMed ID: 6427363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
